NeoVac is a clinical-stage company creating a revolutionary, unique and proprietary next-generation lipid nanoparticles platform to enable better RNA vaccines and medicines for various diseases.
Allowing more people around the world access to better and more potent vaccines, using cutting-edge technology that makes RNA vaccines more transportable, with broader capabilities and fewer side effects.
Company Details
- Employees
- 26
- Founded
- 2021
- Address
- Suites 1 And 2 127 Olympic Avenue, Milton Park,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neovac.co.uk
- Keywords
- Akamis Bio.
- HQ
- Abingdon
Neovac Questions
Neovac's website is http://www.neovac.co.uk
Neovac's LinkedIn profile is https://uk.linkedin.com/company/neovacuk
Neovac has
26 employees.
View email and phone details for 26
employees at Neovac.
Neovac's industry is
Biotechnology Research
Neovac's categories are Biotechnology Research
Neovac's founding year is 2021
